Replies to post #133558 on Biotech Values

[DewDiligence]

During the call yesterday, Teva said its generic Tricor will not be launched in 2012 (no explanation was given).

Perhaps the timing of Teva’s TriCor launch under the settlement was dependent on the now-defunct Certriad being on the market.